Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NeoOncoRx to develop and market elsamitrucin

Nov. 9, 2001

FDA grants orphan drug status for Thymitaq in treatment of HCC

Nov. 9, 2001

FDA issues nonapprovable letter for IntraDose

Nov. 9, 2001

TAP prodrug of duocarmycin derivative shows increased tumor specificity

Nov. 9, 2001

Antitumor activity of new VEGFR2 inhibitor under study at Boehringer Ingelheim

Nov. 9, 2001

Inhibitors of MEK potentially useful for proliferative disorders described in patent

Nov. 8, 2001

Novel cancer-related protein identified by Georgetown and NeoPharm

Nov. 8, 2001

Clinical evaluation of novel anticancer agent CT-2584 summarized at recent meeting

Nov. 8, 2001

Optimal dose and schedule of administration determined for Apomine

Nov. 8, 2001

Orally active taxane profiled at recent international cancer conference

Nov. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...